The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)
Marc A. Judson(Cleveland Clinic), Robert P. Baughman(University of Cincinnati), Rachel Vancavage(Albany Medical Center Hospital), Noopur Singh(Pulmonary Fibrosis Foundation), Marcel Veltkamp(University Medical Center Utrecht), Jennifer L. Beaumont(Northwestern University), Nabeel Hamzeh(American Thoracic Society), Recai Yucel(Temple University), T. Shivas(Pulmonary Fibrosis Foundation), Dominique Valeyre(Inserm), Edward S. Chen(American Thoracic Society), David Victorson(Northwestern University), Nadera Sweiss(University of Illinois Chicago), Elyse E. Lower(University of Cincinnati), Daniel A. Culver(Cleveland Clinic), Sara Preston(St. George's University)
Cited by 4
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Sarcoidosis
|The Lancet|2013|1.1k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k